Home
Conditions
Peripheral T Cell Lymphoma

Clinical trial condition

Peripheral T Cell Lymphoma

Explore clinical trials studying Peripheral T Cell Lymphoma. Study availability and eligibility vary by location and protocol.

52 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Peripheral T Cell Lymphoma trial results

Recruiting

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

NCT07389616

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai General hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Evaluate the Safety and Clinical Activity of HH2853

NCT04390737

Conditions: Advanced Solid Tumor, Epithelioid Sarcoma, FL Lymphoma, +15 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Mayo Clinic Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

NEXT Oncology San Antonio, Texas, United States

View all 25 locations

View Trial Details

Recruiting

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR

NCT07353840

Conditions: Disease Attributes, Disease Progression, Hemic and Lymphatic Diseases, +14 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

NCT07093710

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

NCT07253129

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

NCT04083495

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States

Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

NCT06244368

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

NCT06151106

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: The First Affiliated Hosptial of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

NCT05958719

Conditions: Epigenetic Repression, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

NCT06468267

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Peripheral T Cell Lymphoma

Peripheral T Cell Lymphoma trial results

Related conditions